Edition:
United Kingdom

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,563.00GBp
16 Nov 2018
Change (% chg)

-58.00 (-1.26%)
Prev Close
4,621.00
Open
4,626.00
Day's High
4,650.00
Day's Low
4,532.00
Volume
2,799,393
Avg. Vol
2,039,238
52-wk High
4,780.00
52-wk Low
2,940.50

Chart for

About

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas... (more)

Overall

Beta: 1.54
Market Cap(Mil.): £35,231.62
Shares Outstanding(Mil.): 908.51
Dividend: 3.85
Yield (%): --

Financials

  SHP.L Industry Sector
P/E (TTM): 66.92 31.23 33.59
EPS (TTM): 0.58 -- --
ROI: 1.15 15.57 15.05
ROE: 2.31 16.94 16.62

EU mergers and takeovers (Nov 16)

BRUSSELS, Nov 16 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

16 Nov 2018

UK Stocks-Factors to watch on Nov 13

Nov 13 Britain's FTSE 100 index is seen opening 15 points higher at 7,068 on Tuesday, according to financial bookmakers. * SHIRE, TAKEDA: Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire, according to documents for the deal published on Monday. * IQE: British chipmaker IQE Plc warned on Monday that its current-year financial results would be lower, after fellow Apple sup

13 Nov 2018

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON Banks, law firms and other advisers stand to earn up to $963 million (£749.3 million) in fees from Takeda Pharmaceutical's $62 billion (48.3 billion pounds) takeover of drugmaker Shire , according to documents for the deal published on Monday.

12 Nov 2018

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire , according to documents for the deal published on Monday.

12 Nov 2018

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON, Nov 12 Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire, according to documents for the deal published on Monday.

12 Nov 2018

Takeda sets vote date, aims to close $62 billion Shire deal Jan. 8

LONDON Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan. 8, signaling its confidence in securing the required support.

12 Nov 2018

Takeda sets vote date, aims to close $62 billion Shire deal on January 8

LONDON Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion (47.92 billion pounds) acquisition of Shire next month and aims to close the deal on Jan. 8, signalling its confidence in securing the required support.

12 Nov 2018

UPDATE 1-Takeda sets vote date, aims to close $62 bln Shire deal Jan. 8

* EU, last key regulator, expected to clear acquisition (Adds latest shares, CEO quote, further detail)

12 Nov 2018

Takeda sets vote date, aims to close $62 bln Shire deal Jan. 8

LONDON, Nov 12 Takeda Pharmaceutical will seek investor backing for its $62 billion acquisition of London-listed Shire next month and aims to close the deal on Jan. 8, the Japanese drugmaker said on Monday.

12 Nov 2018

UPDATE 1-UK Stocks-Factors to watch on Nov 12

Nov 12 Britain's FTSE 100 index is seen opening 56 points higher at 7,161 on Monday, according to financial bookmakers, with futures up nearly 0.71 percent ahead of the cash market open.

12 Nov 2018

Earnings vs. Estimates